Prosecution Insights
Last updated: November 06, 2026
Application No. 18/942,074

Probiotic Cleaning Composition and Method of Making and Using the Same

Non-Final OA §102§103
Filed
Nov 08, 2024
Priority
Nov 10, 2023 — provisional 63/597,982 +1 more
Examiner
ELHILO, EISA B
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Energizer Brands LLC
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1214 granted / 1463 resolved
+18.0% vs TC avg
Strong +16% interview lift
Without
With
+16.2%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
45 currently pending
Career history
1510
Total Applications
across all art units

Statute-Specific Performance

§101
2.7%
-37.3% vs TC avg
§103
39.7%
-0.3% vs TC avg
§102
18.8%
-21.2% vs TC avg
§112
24.3%
-15.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1463 resolved cases

Office Action

§102 §103
Claims 1-24 are pending in this application. DETAILED ACTION Notice of Pre-AIA or AIA Status 1 The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 2 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 4-7, 9-15 and 19-24 are rejected under 35 U.S.C. 102(a)1/102(b)1 as being anticipated by Lant et al. (US 2023/0039859 A1). Lant et al. (US’ 859 A1) teaches an aqueous cleaning composition comprising hydrogen peroxide, bacterial spores and water as claimed in claim 1 (see abstract), wherein the bacterial spores are Bacillus spores and include Bacillus amyloliquefaciens, Bacillus pumilus and Bacillus licheniformis as claimed in claims 4-7 (see claims 5-7), wherein the aqueous cleaning composition also comprises surfactants include nonionic surfactants, cationic surfactants and anionic surfactants as claimed in claim 9 (see page 2, paragraph, 0024), wherein the nonionic surfactants include alkylpolyglycosides as claimed in claim 10 (see page 5, paragraph, 0049), wherein the aqueous cleaning composition also comprises citric acid (Buffer) as claimed in claims 11-12 (see page 2, paragraph, 0024) and perfume (fragrance) as claimed in claim 15 (see page 2, paragraph, 0024), wherein the aqueous cleaning composition also comprises phosphate builder (acid-based stabilizer) as claimed in claims 13-14 (see page 2, paragraph, 0024). Lant et al. (US’ 859 A1) further, teaches a method of laundering of a fabric wherein the method comprises the step of contacting the solid composition to water to form a wash liquor and laundering fabric (textile) in said wash liquor at a washing machine and wherein the wash liquor (aqueous) composition comprising hydrogen peroxide, bacterial spores as claimed in claims 19-24 (see page 9, paragraphs, 0122-0126, claims 1 and 8). Lant et al. (US’ 859 A1) teaches all the limitations of the instant claims. Hence, Lant et al. (US’ 859 A1) anticipates the claims. Claim Rejections - 35 USC § 103 3 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 2, 3, 8 and 16 are rejected under 35 U.S.C. 103 as being unpatentable over Lant et al. (US 2023/0039859 A1). Lant et al. (US’ 859 A1) teaches an aqueous cleaning composition comprising bacterial spores in the amount of about 1x102 to about 1x1011 CFU/g as claimed in claims 8 and 16 and hydrogen peroxide in the amount of from about 5% to about 25% by wt., of the composition, which is overlapped with the claimed percentage range as claimed in claims 2 and 16 and closed to the claimed percentage range as claimed in claims 3 (see abstract) and wherein the aqueous composition comprises water in the amount of 90 litres or less (see page, 9, paragraph, 0126). Therefore, in view of the teaching of Lant et al. (US’ 859 A1), it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, to optimize the amounts of hydrogen peroxide, bacterial spores and water in the aqueous cleaning composition in order to get the maximum effective amounts of hydrogen peroxide, bacterial spores and water in the cleaning composition, and, thus, the person of the ordinary skill in the art would expect such an aqueous cleaning composition to have similar results to those claimed, absent unexpected results. 4 Claims 17-18 are rejected under 35 U.S.C. 103 as being unpatentable over Lant et al. (US 2023/0039859 A1) in view of the Patent No. FR 2928377 A1. English translation of the Patent No. FR 2928377 A1 is used in this Office action. Lant et al. (US’ 859 A1) as described above, does not teach or disclose citric acid and its sodium salt (citrate) and phosphoric acid in the claimed amounts as claimed in claims 17 and 18. The Patent No. (FR’ 377 A1) in analogous art of aqueous detergent formulation, teaches a detergent composition diluted with water and useful for treatment of textile (see the Title and the abstract), wherein the composition comprises citric acid and acid salts such as sodium in the amount of 2% and 15% by wt., phosphoric acid in the amount of 2% and 30% by wt., and surfactants in the amounts of from 0.5% to 10% by wt., as claimed in claims 17 and 18 (see page 64, paragraph, 2). Therefore, in view of the teaching of the secondary reference of the Patent No. (FR’ 377 A1), it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, to optimize the amounts of these organic acids and their salts in the aqueous cleaning composition in order to get the maximum effective amounts of these acids, and the person of the ordinary skill in the art would except that the use of these acids as taught by The Patent No. (FR’ 377 A1) would be similarly useful and applicable to the analogous detergent composition taught by Lant et al. (US’ 859 A1), absent unexpected results. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to EISA B ELHILO whose telephone number is (571)272-1315. The examiner can normally be reached Monday-Friday, 7:00 AM to 3:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at (571)272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EISA B ELHILO/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Nov 08, 2024
Application Filed
Aug 17, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779364
NANOFLUID COMPOSITION FOR DISPLACEMENT OF ENTRAINED CONTAMINANTS FROM RESTRICTED GEOMETRIES AND CAPILLARY FEATURES
2y 6m to grant Granted Nov 03, 2026
Patent 12782770
METHOD FOR MANUFACTURING SUCH A DISPLAY SCREEN
2y 0m to grant Granted Nov 03, 2026
Patent 12773650
ENHANCED EXTRACTION OF NATURAL PRODUCTS FROM BIOMASS
3y 4m to grant Granted Oct 27, 2026
Patent 12768098
METHOD FOR PRODUCING CARBAMATED CELLULOSE FIBERS
2y 8m to grant Granted Oct 20, 2026
Patent 12767830
OIL-SOLUBLE BEETROOT RED PIGMENT AND PREPARATION METHOD AND APPLICATION THEREOF
1y 11m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+16.2%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1463 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month